Drug information for TRI-PREVIFEM

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL-28 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG Prescription AB  ETHINYL ESTRADIOL; NORGESTIMATE norgestimate VINTAGE 76335
2007-07-06 Review

Drug Adverse Effects information for TRI-PREVIFEM

Role code Indications Reaction # Reports
PS CONTRACEPTION DRUG EFFECT DECREASED 1
PS CONTRACEPTION HYPERSENSITIVITY 1
PS CONTRACEPTION HYPOAESTHESIA ORAL 1
PS CONTRACEPTION LIP SWELLING 1
PS CONTRACEPTION MATERNAL EXPOSURE DURING PREGNANCY 1
PS CONTRACEPTION METRORRHAGIA 2
PS CONTRACEPTION OROPHARYNGEAL PAIN 1
PS CONTRACEPTION PREGNANCY ON ORAL CONTRACEPTIVE 2
PS CONTRACEPTION PRODUCT PACKAGING ISSUE 3
PS CONTRACEPTION PRODUCT QUALITY ISSUE 5
PS CONTRACEPTION PRODUCT SUBSTITUTION ISSUE 1
PS CONTRACEPTION PRURITUS 1
PS CONTRACEPTION RASH 1
PS CONTRACEPTION UNINTENDED PREGNANCY 1
PS ORAL CONTRACEPTION ABDOMINAL DISCOMFORT 1
PS ORAL CONTRACEPTION NAUSEA 1
SS ORAL CONTRACEPTION UNINTENDED PREGNANCY 3
C MENSTRUAL CYCLE MANAGEMENT PULMONARY THROMBOSIS 2
C MENSTRUAL CYCLE MANAGEMENT THROMBOSIS 2
Ads by Google